https://www.selleckchem.com/pr....oducts/semaxanib-su5
To improve the predictive ability of literature models for model-informed therapeutic drug monitoring (TDM) of meropenem in intensive care units, we propose to tweak the literature models with the "prior approach" using a subset of the data. This study compares the predictive ability of both literature and tweaked models on TDM concentrations of meropenem in critically ill patients. Blood samples were collected from patients of an intensive care unit treated with intravenous meropenem. Data were split six times into an "estimat
Beğen
Yorum Yap
Paylaş
